文献速递细胞病理与分子病理

Hürthle细胞为主甲状腺细针穿刺中孤立与多发结节的恶性风险:多机构研究

Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
PubMed 文献 · Cancer Cytopathol · 2019-11-21

本研究纳入698例Hürthle细胞为主细针穿刺标本,分析孤立与多发结节及淋巴细胞性甲状腺炎背景下恶性风险差异。结果显示多发结节与淋巴细胞性甲状腺炎均未显著影响恶性率,仅结节大小在良恶性间有显著差异。结论认为仅凭多结节性将Hürthle细胞为主穿刺归为AUS而非HUR并不合理。

要点

  • 多结节性不是将Hürthle细胞为主穿刺降级为AUS的充分依据
  • 结节大小在良恶性结节间存在显著差异(P<0.01)
  • 淋巴细胞性甲状腺炎对恶性率的影响呈统计趋势但未达显著

核心结论

  • 多发结节或淋巴细胞性甲状腺炎存在时恶性率无显著差异,仅后者呈统计趋势。
  • 仅基于多结节性将Hürthle细胞为主穿刺诊断为AUS而非HUR并不合理。

研究设计与样本

  • 多机构研究,识别698例Hürthle细胞为主细针穿刺标本并与超声及手术病理报告关联。
  • 576例结节接受切除,其中455例(79%)为良性;无影像结果时多结节性依据大体检查确定。

主要发现

  • HUR的总体恶性风险为27%,AUS的恶性风险为10%。
  • 良性结节平均大小2.1 cm(手术切除标本),多发结节293例(64%),组织学淋巴细胞性甲状腺炎116例(25%)。
  • 恶性结节平均大小2.8 cm,多发结节74例(61%),组织学淋巴细胞性甲状腺炎22例(18%)。
  • 恶性率在孤立与多发结节间无差异(P=.52),在有无淋巴细胞性甲状腺炎间也无差异(P=.12)。
  • 结节大小在良恶性结节间有显著差异(P<0.01)。

临床怎么用

  • 对于Hürthle细胞为主细针穿刺,不应仅因多结节性而将其从HUR降级为AUS。
  • 结节大小对恶性风险评估有参考价值,需结合其他临床病理特征综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hürthle cell metaplasia is common in hyperplastic nodules, particularly within the setting of lymphocytic thyroiditis (LT). The Bethesda System for Reporting Thyroid Cytopathology indicates that it is acceptable to classify Hürthle cell-predominant fine-needle aspiration (HC FNA) specimens as atypia of undetermined significance (AUS) rather than suspicious for a Hürthle cell neoplasm (HUR) within the setting of multiple nodules or known LT. The goal of the current study was to address whether this approach is justified. METHODS: HC FNA specimens were identified and correlated with ultrasound and surgical pathology reports if available. Multinodularity was determined based on findings on macroscopic examination if imaging results were unavailable. RESULTS: A total of 698 HC FNA specimens were identified, including 576 resected nodules, 455 of which (79%) were benign. The overall risk of malignancy for HUR was 27%, whereas the risk of malignancy for AUS was 10%. The mean size of the benign nodules was 2.1 cm on surgical resection specimens, with multiple nodules noted in 293 cases (64%) and histologic LT noted in 116 cases (25%). The mean size of the malignant nodules was 2.8 cm, with multiple nodules and histologic LT noted in 74 cases (61%) and 22 cases (18%), respectively. The malignancy rate did not differ between solitary or multiple nodules (P = .52) or in the presence or absence of LT (P = .12). However, size did significantly differ between malignant and benign nodules (P < 0.01). CONCLUSIONS: The malignancy rate did not differ significantly in the presence of multiple nodules or LT, although the latter demonstrated a statistical trend. A diagnosis of AUS over HUR based solely on the presence of multinodularity is not warranted.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Wong KS, Jo VY, Lowe AC, et al. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study. Cancer Cytopathol. 2019. PMID: 31751003. doi:10.1002/cncy.22213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。